News

Bedtime dosing with antihypertensive medication yields better nocturnal blood pressure control and improved circadian rhythm.
The FDA has updated the labeling for Kisunla™ (donanemab-azbt) to include a new recommended titration dosing schedule for adults with early symptomatic Alzheimer disease.
The amended dosing regimen was approved based on results from a post hoc analysis of the phase 2 MagnetisMM-3 trial.
Verywell Health on MSN1d
13 Ways to Lower Your Heart Rate
You can lower your heart rate with lifestyle changes like regular exercise and stress management. Learn more tips and when to ...